Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus (VALUE)
Sponsor: Ampel BioSolutions, LLC
A observational or N/A phase clinical study on Lupus Erythematosus, Systemic and SLE, this trial is completed. The trial is conducted by Ampel BioSolutions, LLC and has accumulated 16 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
16 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2023 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Dec 2023 [monthly]
Completed
▶ Show 11 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jan 2019 — Nov 2020 [monthly]
Completed
-
Oct 2018 — Jan 2019 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jul 2018 — Oct 2018 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Recruiting NA
-
Aug 2017 — Sep 2017 [monthly]
Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ampel BioSolutions, LLC
- Lupus Research Alliance
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .